Year |
Citation |
Score |
2022 |
Murray-Brown W, Guo Y, Small A, Lowe K, Weedon H, Smith MD, Lester SE, Proudman SM, Rao NL, Hao LY, Nagpal S, Wechalekar MD. Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium. Rmd Open. 8. PMID 36270740 DOI: 10.1136/rmdopen-2022-002563 |
0.428 |
|
2018 |
Xiao P, Guo Y, Zhang H, Zhang X, Cheng H, Cao Q, Ke Y. Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment. Oncogene. PMID 29795405 DOI: 10.1038/s41388-018-0337-6 |
0.339 |
|
2018 |
Cole S, Walsh A, Yin X, Wechalekar MD, Smith MD, Proudman SM, Veale DJ, Fearon U, Pitzalis C, Humby F, Bombardieri M, Axel A, Adams H, Chiu C, Sharp M, ... ... Guo Y, et al. Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research & Therapy. 20: 85. PMID 29720240 DOI: 10.1186/S13075-018-1578-Z |
0.469 |
|
2018 |
Guo Y, Walsh AM, Canavan M, Wechalekar MD, Cole S, Yin X, Scott B, Loza M, Orr C, McGarry T, Bombardieri M, Humby F, Proudman SM, Pitzalis C, Smith MD, et al. Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. Plos One. 13: e0192704. PMID 29489833 DOI: 10.1371/Journal.Pone.0192704 |
0.409 |
|
2017 |
Walsh AM, Wechalekar MD, Guo Y, Yin X, Weedon H, Proudman SM, Smith MD, Nagpal S. Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. Plos One. 12: e0183928. PMID 28863153 DOI: 10.1371/Journal.Pone.0183928 |
0.45 |
|
2017 |
Guo Y, Walsh AM, Fearon U, Smith MD, Wechalekar MD, Yin X, Cole S, Orr C, McGarry T, Canavan M, Kelly S, Lin TA, Liu X, Proudman SM, Veale DJ, et al. CD40L-Dependent Pathway Is Active at Various Stages of Rheumatoid Arthritis Disease Progression. Journal of Immunology (Baltimore, Md. : 1950). PMID 28455435 DOI: 10.4049/Jimmunol.1601988 |
0.514 |
|
2017 |
Walsh A, Canavan M, Guo Y, McGarry T, Yin X, Wechalekar, Smith, Proudman S, Orr C, Kelly S, Pitzalis C, Veale D, Fearon U, Nagpal S. THU0011 Immune signal 2 checkpoint molecule expression in rheumatoid arthritis disease progression Annals of the Rheumatic Diseases. 76: 203-204. DOI: 10.1136/Annrheumdis-2017-Eular.1343 |
0.542 |
|
2016 |
Guo Y, MacIsaac KD, Chen Y, Miller RJ, Jain R, Joyce-Shaikh B, Ferguson H, Wang IM, Cristescu R, Mudgett J, Engstrom L, Piers KJ, Baltus GA, Barr K, Zhang H, et al. Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity. Cell Reports. 17: 3206-3218. PMID 28009290 DOI: 10.1016/J.Celrep.2016.11.073 |
0.409 |
|
2015 |
Guo Y, Wang AY. Novel Immune Check-Point Regulators in Tolerance Maintenance. Frontiers in Immunology. 6: 421. PMID 26347744 DOI: 10.3389/fimmu.2015.00421 |
0.341 |
|
2015 |
Guo Y, Brown C, Ortiz C, Noelle RJ. Leukocyte homing, fate, and function are controlled by retinoic acid. Physiological Reviews. 95: 125-48. PMID 25540140 DOI: 10.1152/Physrev.00032.2013 |
0.686 |
|
2014 |
Guo Y, Lee YC, Brown C, Zhang W, Usherwood E, Noelle RJ. Dissecting the role of retinoic acid receptor isoforms in the CD8 response to infection. Journal of Immunology (Baltimore, Md. : 1950). 192: 3336-44. PMID 24610012 DOI: 10.4049/Jimmunol.1301949 |
0.684 |
|
2013 |
Aoyama K, Saha A, Tolar J, Riddle MJ, Veenstra RG, Taylor PA, Blomhoff R, Panoskaltsis-Mortari A, Klebanoff CA, Socié G, Munn DH, Murphy WJ, Serody JS, Fulton LM, Teshima T, ... ... Guo Y, et al. Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood. 122: 2125-34. PMID 23814022 DOI: 10.1182/Blood-2012-11-470252 |
0.657 |
|
2013 |
Guo Y, Nolle RJ. Retinoic acid on stage in antitumor immunity. Oncoimmunology. 2: e22985. PMID 23526574 DOI: 10.4161/Onci.22985 |
0.623 |
|
2013 |
Zhang Z, Meng Y, Guo Y, He X, Liu Q, Wang X, Shan F. Rehmannia glutinosa polysaccharide induces maturation of murine bone marrow derived Dendritic cells (BMDCs). International Journal of Biological Macromolecules. 54: 136-43. PMID 23246902 DOI: 10.1016/j.ijbiomac.2012.12.005 |
0.328 |
|
2012 |
Guo Y, Pino-Lagos K, Ahonen CA, Bennett KA, Wang J, Napoli JL, Blomhoff R, Sockanathan S, Chandraratna RA, Dmitrovsky E, Turk MJ, Noelle RJ. A retinoic acid--rich tumor microenvironment provides clonal survival cues for tumor-specific CD8(+) T cells. Cancer Research. 72: 5230-9. PMID 22902413 DOI: 10.1158/0008-5472.Can-12-1727 |
0.781 |
|
2011 |
Pino-Lagos K, Guo Y, Brown C, Alexander MP, Elgueta R, Bennett KA, De Vries V, Nowak E, Blomhoff R, Sockanathan S, Chandraratna RA, Dmitrovsky E, Noelle RJ. A retinoic acid-dependent checkpoint in the development of CD4+ T cell-mediated immunity. The Journal of Experimental Medicine. 208: 1767-75. PMID 21859847 DOI: 10.1084/Jem.20102358 |
0.721 |
|
2011 |
Byrne KT, Côté AL, Zhang P, Steinberg SM, Guo Y, Allie R, Zhang W, Ernstoff MS, Usherwood EJ, Turk MJ. Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanoma. The Journal of Clinical Investigation. 121: 1797-809. PMID 21540555 DOI: 10.1172/Jci44849 |
0.548 |
|
2011 |
Wang L, Rubinstein R, Lines JL, Wasiuk A, Ahonen C, Guo Y, Lu LF, Gondek D, Wang Y, Fava RA, Fiser A, Almo S, Noelle RJ. VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. The Journal of Experimental Medicine. 208: 577-92. PMID 21383057 DOI: 10.1084/Jem.20100619 |
0.745 |
|
2010 |
Pino-Lagos K, Guo Y, Noelle RJ. Retinoic acid: a key player in immunity. Biofactors (Oxford, England). 36: 430-6. PMID 20803520 DOI: 10.1002/Biof.117 |
0.748 |
|
2009 |
Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews. 229: 152-72. PMID 19426221 DOI: 10.1111/J.1600-065X.2009.00782.X |
0.652 |
|
Show low-probability matches. |